1-1     By:  Gray, et al. (Senate Sponsor - Moncrief)          H.B. No. 915
 1-2           (In the Senate - Received from the House May 1, 2001;
 1-3     May 2, 2001, read first time and referred to Committee on Health
 1-4     and Human Services; May 8, 2001, reported adversely, with favorable
 1-5     Committee Substitute by the following vote:  Yeas 8, Nays 0;
 1-6     May 8, 2001, sent to printer.)
 1-7     COMMITTEE SUBSTITUTE FOR H.B. No. 915                 By:  Moncrief
 1-8                            A BILL TO BE ENTITLED
 1-9                                   AN ACT
1-10     relating to bulk purchasing of prescription drugs by certain state
1-11     agencies.
1-12           BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS:
1-13           SECTION 1. Subtitle E, Title 2, Health and Safety Code, is
1-14     amended by adding Chapter 110 to read as follows:
1-15                    CHAPTER 110.  INTERAGENCY COUNCIL ON
1-16                       PHARMACEUTICALS BULK PURCHASING
1-17           Sec. 110.001.  DEFINITION. In this chapter, "council" means
1-18     the Interagency Council on Pharmaceuticals Bulk Purchasing.
1-19           Sec. 110.002.  BULK PURCHASING COUNCIL. The Interagency
1-20     Council on Pharmaceuticals Bulk Purchasing is composed of an
1-21     officer or employee from each of the following agencies, appointed
1-22     by the administrative head of that agency:
1-23                 (1)  the Texas Department of Health;
1-24                 (2)  the Texas Department of Mental Health and Mental
1-25     Retardation;
1-26                 (3)  the Correctional Managed Health Care Committee;
1-27                 (4)  the Employees Retirement System of Texas;
1-28                 (5)  the Teacher Retirement System of Texas; and
1-29                 (6)  any other agency that purchases pharmaceuticals
1-30     designated by the commissioner of health and human services.
1-31           Sec. 110.003.  PRESIDING OFFICER. The position of presiding
1-32     officer rotates among the members of the council according to the
1-33     procedures adopted by the council. A term as presiding officer is
1-34     two years and expires on February 1 of each odd-numbered year.
1-35           Sec. 110.004.  COMPENSATION. Service on the council is an
1-36     additional duty of a member's office or employment.  A member of
1-37     the council is not entitled to compensation, but is entitled to
1-38     reimbursement of travel expenses incurred by the member while
1-39     conducting the business of the council, as provided in the General
1-40     Appropriations Act.
1-41           Sec. 110.005.  SUPPORT STAFF. The council's member agencies
1-42     shall provide the staff for the council.
1-43           Sec. 110.006.  COUNCIL POWERS AND DUTIES. (a)  The council
1-44     shall develop procedures that member agencies must follow in
1-45     purchasing pharmaceuticals other than medical assistance under the
1-46     vendor drug program.  A member agency may elect not to follow the
1-47     council's procedures if the agency can purchase the pharmaceuticals
1-48     for a lower price than through the council.  An agency that does
1-49     not follow the council's procedures shall report to the council:
1-50                 (1)  the purchase price for the pharmaceuticals; and
1-51                 (2)  the name of the wholesaler, retailer, or
1-52     manufacturer selling the pharmaceuticals.
1-53           (b)  The council shall designate one member agency to be the
1-54     central purchasing agency for purchasing pharmaceuticals.
1-55           (c)  The council shall use existing distribution networks,
1-56     including wholesale and retail distributors, to distribute the
1-57     pharmaceuticals.
1-58           (d)  The council shall:
1-59                 (1)  investigate any and all options for better
1-60     purchasing power, including expanding Medicaid purchasing,
1-61     qualifying for participation in purchasing programs under 42 U.S.C.
1-62     Section 256b, and using rebate programs, hospital disproportionate
1-63     share purchasing, and health department and federally qualified
1-64     health center purchasing; and
 2-1                 (2)  make recommendations regarding drug  utilization
 2-2     review, prior authorization, the use of restrictive formularies,
 2-3     the use of mail order programs, and copayment structures to member
 2-4     agencies.
 2-5           (e)  In conducting the study under Subsection (d), the
 2-6     council shall monitor the progress of the demonstration project for
 2-7     certain medications and related services established by Section
 2-8     32.053, Human Resources Code, as added by S.B. 1156, 77th Regular
 2-9     Session, and make no recommendations inconsistent with a prescribed
2-10     medical regime for those medications.
2-11           (f)  The council may enter into agreements with a local
2-12     governmental entity to purchase pharmaceuticals for the local
2-13     governmental entity.
2-14           (g)  The council shall develop procedures under which the
2-15     council may disclose information relating to the prices that
2-16     manufacturers or wholesalers charge for pharmaceuticals by category
2-17     of pharmaceutical.  The council may not disclose information that
2-18     identifies a specific manufacturer or wholesaler or the prices
2-19     charged by a specific manufacturer or wholesaler for a specific
2-20     pharmaceutical.
2-21           SECTION 2.  Subchapter E, Chapter 431, Health and Safety
2-22     Code, is amended by adding Section 431.116 to read as follows:
2-23           Sec. 431.116.  AVERAGE MANUFACTURER PRICE. (a)  In this
2-24     section, "average manufacturer price" has the meaning assigned by
2-25     42 U.S.C. Section 1396r-8(k), as amended.
2-26           (b)  A person who manufactures a drug, including a person who
2-27     manufactures a generic drug, that is sold in this state shall file
2-28     with the department:
2-29                 (1)  the average manufacturer price for the drug; and
2-30                 (2)  the price that each wholesaler in this state pays
2-31     the manufacturer to purchase the drug.
2-32           (c)  The information required under Subsection (b) must be
2-33     filed annually or more frequently as determined by the department.
2-34           (d)  The department and the attorney general may investigate
2-35     the manufacturer to determine the accuracy of the information
2-36     provided under Subsection (b).  The attorney general may take
2-37     action to enforce this section.
2-38           (e)  The department shall report the information collected
2-39     under Subsection (b) to the Interagency Council on Pharmaceuticals
2-40     Bulk Purchasing.
2-41           SECTION 3.  This Act takes effect September 1, 2001.
2-42                                  * * * * *